Recurrence of First Afebrile Unprovoked Seizure and Parental Consanguinity: A Hospital-Based Study

Miral A Al Momani1,2, Basima Almomani3, Salar Bani Hani2

  • 1Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.

Insights

Recurrent seizures in children are common, with over half experiencing a second attack. Parental consanguinity and focal seizures increase this risk, highlighting the need for public awareness.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Public Health

Background:

  • First unprovoked seizures in children represent a significant clinical concern.
  • Understanding recurrence risk factors is crucial for management and prognosis.

Purpose of the Study:

  • To determine the incidence of first unprovoked seizures in children.
  • To identify clinical characteristics and risk factors for seizure recurrence.

Main Methods:

  • Retrospective observational study.
  • Evaluation of medical records for children aged 1 month to 16 years.
  • 1-year follow-up period for seizure recurrence.

Main Results:

  • High incidence of first unprovoked seizures (441 per 100,000 pediatric visits).
  • Over half (55.3%) of children experienced seizure recurrence.
  • Parental consanguinity (OR=2.785) and focal seizures (OR=1.798) significantly increased recurrence risk.

Conclusions:

  • Parental consanguinity and focal seizures are key risk factors for pediatric seizure recurrence.
  • Findings emphasize the need for public education on consanguinity's impact on health outcomes.
  • Improved awareness can enhance quality of life for affected children.
Abstract

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.2K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.0K
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
130
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.4K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
714